APPLICATION SITE PERSPIRATION

This adverse event was reported 173 times

These drugs are most commonly taken by patients reporting APPLICATION SITE PERSPIRATION:

# Drug Count
0 BUPRENORPHINE 45
1 NICOTINE 30
2 OXYCODONE 21
3 CYCLOBENZAPRINE 18
4 DULOXETINE 17
5 DULOXETINE HYDROCHLORIDE 17
6 QUETIAPINE 17
7 TOPIRAMATE 16
8 FENTANYL 8
9 QUETIAPINE FUMARATE 8
See all common drugs associated with APPLICATION SITE PERSPIRATION

APPLICATION SITE PERSPIRATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NICOTINE 30 0.0007
1 NORELGESTROMIN AND ETHINYL ESTRADIOL 1 0.0005
2 ESTRADIOL AND LEVONORGESTREL 1 0.0005
3 BUPRENORPHINE 45 0.0005
4 CYCLOBENZAPRINE 18 0.0004
5 TOPIRAMATE 16 0.0003
6 DULOXETINE HYDROCHLORIDE 17 0.0002
7 DICLOFENAC EPOLAMINE 1 0.0002
8 IRBESARTAN AND HYDROCHLOROTHIAZIDE 1 0.0002
9 FENTANYL CITRATE 3 0.0002
See all drugs enriched for association with APPLICATION SITE PERSPIRATION

APPLICATION SITE PERSPIRATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholinergic Nicotinic Agonist [EPC] 33 0.0005
1 Partial Opioid Agonist [EPC] 45 0.0005
2 Provitamin D2 Compound [EPC] 3 0.0001
3 Arteriolar Vasodilator [EPC] 7 0.0001
4 Opioid Agonist [EPC] 24 0.0001
5 Amide Local Anesthetic [EPC] 7 0.0001
6 Antiarrhythmic [EPC] 7 0.0001
7 Estrogen [EPC] 12 0.0001
8 Progesterone [EPC] 1 0.0000
9 Soluble Guanylate Cyclase Stimulator [EPC] 1 0.0000
See all drug classes enriched for association with APPLICATION SITE PERSPIRATION